Sinovac Biotech Ltd. – NasdaqGS: SVA
Another 52 week stock. This one hit it on Friday at $5.20.
They reported outstanding results in their press release of August 13th: (unaudited numbers)
Second Quarter 2013 Financial Highlights (period-over-period comparisons to second quarter 2012)
- Total sales increased by 86.4% to $17.5 million from $9.4 million.
- Gross profit increased by 70.1% to $13.6 million from $8.0 million.
- Net income attributable to common stockholders was $1.3 million, or $0.02 per basic and diluted share, compared to net loss attributed to common stockholders of $1.6 million, or $0.03 per basic and diluted share.
- Cash and cash equivalents totaled $92.0 million as of June 30, 2013, compared to $91.2 million as of December 31, 2012.
This one is strong. I know a lot of people are always a bit careful when looking at stocks from Chinese companies because of the recent history. They are strong and the cash position is great. Sales are great. What more can you ask for?